COMBINED PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES ON ALPRENOLOL AND 4-HYDROXY-ALPRENOLOL IN MAN

被引：62

作者：

ABLAD, B

BORG, KO

JOHNSSON, G

REGARDH, CG

SOLVELL, L

机构：

[1] AB HASSLE,RES LABS,HASSLE,SWEDEN

[2] SAHLGRENS HOSP,DEPT MED,GOTHENBURG,SWEDEN

来源：

关键词：

D O I：

10.1016/0024-3205(74)90452-4

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：693 / 704

页数：12

共 14 条

[1] PHARMACOLOGICAL EFFECTS AND SERUM LEVELS OF ORALLY ADMINISTERED ALPRENOLOL IN MAN
ABLAD, B
HALLGREN, J
SOLVELL, L
JOHNSSON, G
ERVIK, M
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 5 (01) : 44 - &
[2] BODIN NO, 1973, SAMBAND MELLAN FARMA
[3] CARLSSON E, 1973, SAMBAND MELLAN FARMA
[4] CLEAVELAND CR, 1972, CLIN PHARMACOL THER, V13, P181
[5] PLASMA PROPRANOLOL LEVELS IN QUANTITATIVE ASSESSMENT OF BETA-ADRENERGIC BLOCKADE IN MAN
COLTART, DJ
SHAND, DG
[J]. BRITISH MEDICAL JOURNAL, 1970, 3 (5725) : 731 - &
[6] Davis P. J., 1967, NUMERICAL INTEGRATIO
[7] PHARMACOLOGY OF 4-HYDROXYPROPRANOLOL, A METABOLITE OF PROPRANOLOL
FITZ GERALD, JD
ODONNELL, SR
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1971, 43 (01) : 222 - +
[8] JOHANSSON R, 1971, ACTA PHARM SUEC, V8, P59
[9] JOHNSSON G, 1967, ACTA PHARMACOL TOX, VS 25, P95
[10] LEVY G, 1966, CLIN PHARMACOL THER, V7, P362